Hennion & Walsh Asset Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-26,066
| Closed | -$1.26M | – | 944 |
|
|
2025
Q1 | $1.26M | Sell |
26,066
-6,008
| -19% | -$291K | 0.06% | 416 |
|
|
2024
Q4 | $1.24M | Sell |
32,074
-5,339
| -14% | -$206K | 0.06% | 413 |
|
|
2024
Q3 | $1.68M | Sell |
37,413
-467
| -1% | -$21K | 0.08% | 321 |
|
|
2024
Q2 | $1.31M | Buy |
37,880
+2,985
| +9% | +$103K | 0.07% | 362 |
|
|
2024
Q1 | $1.01M | Buy |
34,895
+849
| +2% | +$24.6K | 0.05% | 420 |
|
|
2023
Q4 | $781K | Buy |
34,046
+2,380
| +8% | +$54.6K | 0.04% | 468 |
|
|
2023
Q3 | $528K | Buy |
31,666
+14,958
| +90% | +$249K | 0.03% | 503 |
|
|
2023
Q2 | $461K | Buy |
+16,708
| New | +$461K | 0.03% | 532 |
|